<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03862261</url>
  </required_header>
  <id_info>
    <org_study_id>EG0214</org_study_id>
    <nct_id>NCT03862261</nct_id>
  </id_info>
  <brief_title>Integrating Pediatric TB Services Into Child Healthcare Services in Africa</brief_title>
  <acronym>INPUT</acronym>
  <official_title>Integrating Pediatric TB Services Into Child Healthcare Services in Africa. A Cluster-randomized Stepped-wedge Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Elizabeth Glaser Pediatric AIDS Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>UNITAID</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Sheffield</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kenya Ministry of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cameroon Ministry of Public Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Elizabeth Glaser Pediatric AIDS Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Under-diagnosis of TB in children is a critical gap to address. The INPUT study is a
      multinational stepped-wedge cluster-randomized intervention study aiming to assess the effect
      of integrating TB services into child healthcare services on TB diagnosis capacities in
      children under 5 years of age.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study clusters (district-level hospitals and their health centers) will start under
      standard-of-care and transition to the intervention at randomly assigned time points.

      In this study two strategies will be compared: i) The standard of care, offering pediatric TB
      services based on current routine approach; ii) The intervention, with pediatric TB services
      integrated into child healthcare services.

      The primary objective will be to assess the effect of the intervention compared to standard
      of care on the proportion of TB cases diagnosed among children &lt;5 years old (that is the
      number of children who are clinically or bacteriologically diagnosed with TB over the total
      number of children attending the child healthcare services). Secondary objectives are
      detailed in the protocol.

      Study sites will include six hospital in each participating country (Cameroon and Kenya)
      along with selected attached health centers.

      The study population will be children aged less than five years of age with a presumptive
      diagnosis of TB.

      Study enrollment will start in March 2019, last enrollments until July 2020 and follow up
      will be completed by August 2021.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 10, 2019</start_date>
  <completion_date type="Anticipated">June 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Cluster-randomized stepped-wedge model, where intervention will be randomly allocated to the different study sites at different time points.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of children diagnosed with active TB</measure>
    <time_frame>up to two months</time_frame>
    <description>Number of pediatric TB cases diagnosed (bacteriologically confirmed and/or clinically diagnosed) over the number of children attending the child healthcare services during the study period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of children screened for TB</measure>
    <time_frame>one month</time_frame>
    <description>Number of children screened for TB over the number of children attending the child healthcare services during the study period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of screened children who have a sample collected</measure>
    <time_frame>up to three months</time_frame>
    <description>Proportion of children who have a sample collected for microbiologic diagnosis among those screened positive for TB (i.e. presumptive TB cases)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of children diagnosed with TB among presumptive TB cases</measure>
    <time_frame>up to two months</time_frame>
    <description>Proportion of children diagnosed with TB (bacteriologically or clinically) among presumptive TB cases, overall and disaggregated by HIV status and nutrition status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from screening to clinical or bacteriologic diagnosis</measure>
    <time_frame>up to three months</time_frame>
    <description>For children finally diagnosed with TB, time elapsed from presumptive to confirmed TB case</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from diagnosis to treatment initiation</measure>
    <time_frame>up to three months</time_frame>
    <description>For children diagnosed with TB, time elapsed to initiate treatment after active TB is confirmed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of cases with a bacteriologically confirmed diagnosis</measure>
    <time_frame>up to three months</time_frame>
    <description>Proportion of cases with a bacteriologically confirmed diagnosis among children diagnosed with TB</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of children who initiate TB treatment among those diagnosed</measure>
    <time_frame>up to two months</time_frame>
    <description>Proportion of children who initiate TB treatment among those diagnosed will give treatment coverage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment outcome</measure>
    <time_frame>8 to 14 months (2 months after treatment completion)</time_frame>
    <description>Treatment outcomes for patients initiated on treatment according to WHO categories: treatment success, treatment failed, died, lost to follow-up, and not evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to the TB treatment</measure>
    <time_frame>6 to 12 months (at treatment completion)</time_frame>
    <description>Adherence documented by seven-day recall and counting of pills</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Tuberculosis</condition>
  <condition>Children, Only</condition>
  <condition>Diagnosis</condition>
  <condition>Delivery of Health Care</condition>
  <arm_group>
    <arm_group_label>Standard-of-Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Pediatric TB services based on current routine approach (national standard of care)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Integrated pediatric TB services</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Integrated pediatric TB services</intervention_name>
    <description>pediatric TB services will be integrated into key child healthcare services: maternal neonatal and child health (MNCH) services, under-5 clinic, pediatric outpatient services, nutrition services, pediatric antiretroviral therapy (ART) services and primary health care:
Integration of the screening into all the child health care services with introduction of a specific case detection tool and updated presumptive TB register.
Improvement of diagnosis capacities and their integration in all levels of care and all services.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children &lt; 5 years old.

          -  TB diagnosis investigations initiated.

          -  Other infectious diseases are not suspected or have already been ruled out.

          -  Commitment to take treatment in the clinic of enrolment or another INPUT study site.

          -  Parental/caregiver consent for the child to participate in the study.

        Exclusion Criteria:

          -  Children who are TB contacts but without symptoms or signs of active TB
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Appolinaire Tiam, MBChB, MMed</last_name>
    <role>Principal Investigator</role>
    <affiliation>Elizabeth Glaser Pediatric AIDS Foundation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Appolinaire Tiam, MBChB, MMed</last_name>
    <phone>+1 202 29909931</phone>
    <email>atiam@pedaids.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lise Denoeud, MD PhD</last_name>
    <phone>+4127916457</phone>
    <email>ldenoeud@pedaids.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital de District Akonolinga</name>
      <address>
        <city>Akonolinga</city>
        <state>Centre</state>
        <country>Cameroon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris K Tchounga, MD PHD</last_name>
      <phone>+237222219790</phone>
      <phone_ext>+237222219790</phone_ext>
      <email>btchounga@pedaids.org</email>
    </contact>
    <investigator>
      <last_name>Boris K Tchounga, MD PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de District Soa</name>
      <address>
        <city>Soa</city>
        <state>Centre</state>
        <country>Cameroon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris K Tchounga, MD PHD</last_name>
      <phone>+237 222219790</phone>
      <email>btchounga@pedaids.org</email>
    </contact>
    <investigator>
      <last_name>Boris K Tchounga, MD PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de District Loum</name>
      <address>
        <city>Loum</city>
        <state>Littoral</state>
        <country>Cameroon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris K Tchounga, MD PHD</last_name>
      <phone>+237222219790</phone>
      <phone_ext>+237222219790</phone_ext>
      <email>btchounga@pedaids.org</email>
    </contact>
    <investigator>
      <last_name>Boris K Tchounga, MD PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de District Foumban</name>
      <address>
        <city>Mbanga</city>
        <state>Littoral</state>
        <country>Cameroon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris K Tchounga, MD PHD</last_name>
      <phone>+237222219790</phone>
      <phone_ext>+237222219790</phone_ext>
      <email>btchounga@pedaids.org</email>
    </contact>
    <investigator>
      <last_name>Boris K Tchounga, MD PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de District Dschang</name>
      <address>
        <city>Dschang</city>
        <state>West</state>
        <country>Cameroon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris K Tchounga, MD PHD</last_name>
      <phone>+237222219790</phone>
      <phone_ext>+237222219790</phone_ext>
      <email>btchounga@pedaids.org</email>
    </contact>
    <contact_backup>
      <last_name>Boris K Tchounga</last_name>
      <phone>+237222219790</phone>
      <phone_ext>+237222219790</phone_ext>
      <email>btchounga@pedaids.org</email>
    </contact_backup>
    <investigator>
      <last_name>Boris K Tchounga, MD PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de District Mbouda</name>
      <address>
        <city>Mbouda</city>
        <state>West</state>
        <country>Cameroon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris K Tchounga, MD PHD</last_name>
      <phone>+237222219790</phone>
      <phone_ext>+237222219790</phone_ext>
      <email>btchounga@pedaids.org</email>
    </contact>
    <contact_backup>
      <last_name>Boris K Tchounga</last_name>
      <phone>+237222219790</phone>
      <phone_ext>+237222219790</phone_ext>
      <email>btchounga@pedaids.org</email>
    </contact_backup>
    <investigator>
      <last_name>Boris K Tchounga, MD PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kendu Sub County Hospital</name>
      <address>
        <city>Kendu Bay</city>
        <state>Homa Bay</state>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rose O Masaba, MD MSc</last_name>
      <phone>+254204454081</phone>
      <phone_ext>+254204454081</phone_ext>
      <email>rmasaba@pedaids.org</email>
    </contact>
    <investigator>
      <last_name>Rose O Masaba, MD Msc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ndhiwa Sub county Hospital</name>
      <address>
        <city>Ndhiwa</city>
        <state>Homa Bay</state>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rose O Masaba, MD MSc</last_name>
      <phone>+254204454081</phone>
      <phone_ext>+254204454081</phone_ext>
      <email>rmasaba@pedaids.org</email>
    </contact>
    <contact_backup>
      <last_name>Rose O Masaba</last_name>
      <phone>+254204454081</phone>
      <phone_ext>+254204454081</phone_ext>
      <email>rmasaba@pedaids.org</email>
    </contact_backup>
    <investigator>
      <last_name>Rose O Masaba, MD MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kakuma Mission Hospital</name>
      <address>
        <city>Kakuma</city>
        <state>Turkana</state>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rose O Masaba, MD MSc</last_name>
      <phone>+254204454081</phone>
      <phone_ext>+254204454081</phone_ext>
      <email>rmasaba@pedaids.org</email>
    </contact>
    <contact_backup>
      <last_name>Rose O Masaba</last_name>
      <phone>+254204454081</phone>
      <phone_ext>+254204454081</phone_ext>
      <email>rmasaba@pedaids.org</email>
    </contact_backup>
    <investigator>
      <last_name>Rose O Masaba, MD MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lokitaung sub-county hospital</name>
      <address>
        <city>Lokitaung</city>
        <state>Turkana</state>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rose O Masaba, MD MSc</last_name>
      <phone>+254 20 44-54-081/2/3</phone>
      <phone_ext>+254204454081</phone_ext>
      <email>rmasaba@pedaids.org</email>
    </contact>
    <contact_backup>
      <last_name>Rose O Masaba</last_name>
      <phone>+254204454081</phone>
      <phone_ext>+254204454081</phone_ext>
      <email>rmasaba@pedaids.org</email>
    </contact_backup>
    <investigator>
      <last_name>Rose O Masaba, MD Msc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lopiding Sub County Hospital</name>
      <address>
        <city>Lopiding</city>
        <state>Turkana</state>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rose O Masaba, MD MSc</last_name>
      <phone>+254204454081</phone>
      <phone_ext>+254204454081</phone_ext>
      <email>rmasaba@pedaids.org</email>
    </contact>
    <investigator>
      <last_name>Rose O Masaba, MD MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Homa Bay County Referral Hospital</name>
      <address>
        <city>Homa Bay</city>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rose O Masaba, MD MSc</last_name>
      <phone>+254204454081</phone>
      <phone_ext>+254204454081</phone_ext>
      <email>rmasaba@pedaids.org</email>
    </contact>
    <investigator>
      <last_name>Rose O Masaba, MD Msc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Cameroon</country>
    <country>Kenya</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>February 12, 2019</study_first_submitted>
  <study_first_submitted_qc>March 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2019</study_first_posted>
  <last_update_submitted>January 27, 2020</last_update_submitted>
  <last_update_submitted_qc>January 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

